P120: TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A CROSSWALK-C TRIAL EVALUATING THE EFFICACY OF CROVALIMAB AS ADJUNCT TREATMENT IN THE PREVENTION OF VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)

Detalles Bibliográficos
Autores principales: Callaghan, M, Ataga, K, De Franceschi, L, Minniti, C, Balachandran, N, Imbs, D, Perretti, T, Ramos, J, Sostelly, A, Bartolucci, P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Poster Presentations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812079/
http://dx.doi.org/10.1097/01.HS9.0000821572.78026.e4

Ejemplares similares

Ejemplares similares